Dr Mike Strange
Mike has over 25 years of experience in the life sciences sector, working as COO and R&D Leader across pharmaceutical and vaccines R&D, and commercial. Mike’s most recent role was Head of Global Health at LifeArc where he led the design and implementation of LifeArc’s strategy in Global Health, a £100m programme of investments focussed […]
Dr Francesca Sadler
Francesca Sadler has 20 years’ commercial experience in the drug discovery and development field. Francesca started her career as a Clinical Scientist working at the Public Health Laboratory Service (now part of Public Health England) researching meningococcal disease. Following a rewarding early career in the laboratory, Francesca moved into the commercial arena, most recently serving […]
Robert Sherville-Payne
With a professional legal and compliance background and over 25 years of commercial experience, Robert brings significant expertise as a solicitor to his role as General Counsel and Company Secretary at Medicines Discovery Catapult. Having trained and worked at law firm Hogan Lovells in London, Robert spent 14 years at AstraZeneca in a range of […]
Sinéad McCormack
Sinéad is a qualified accountant with 23 years of experience, holding senior positions in financial services and higher education with organisations including Barclays, Bank of England and the University of Manchester. Having started her career with Aspect Capital, AIG and Barclays, Sinéad then joined the Bank of England as Senior Manager of Financial of Control […]
Clare Atherton
Clare brings a plethora of HR experience gained throughout her career in the rail, retail, FMCG, science and technology sectors to her role as Chief People Officer at Medicines Discovery Catapult (MDC). Having started her career within the Rail sector, Clare has held senior positions in private and public sector organisations – most recently with […]
Dr Nicola Heron
Nicola has over 26 years of life science experience, holding senior positions across the public and private sectors in organisations including AstraZeneca and the NHS. With a broad range of experience from research to commercialisation in pharmaceuticals, medical devices and diagnostics, Nicola brings a breadth of experience to her role as Chief Strategy Officer at […]
Professor Chris Molloy
Professor Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines. His career began in preclinical research at Glaxo, where he was closely involved with the industrialisation of high throughput discovery. In 2004 he moved to Asia as COO of MerLion Pharmaceuticals, a Singaporean biotech that […]